Article
Glycolytic Inhibitor 2-Deoxy-D-Glucose Attenuates SARS-CoV-2 Multiplication in Host Cells and Weakens the Infective Potential of Progeny Virions
2022-01-10
Abstract excerpt
The COVID-19 pandemic is an ongoing public health emergency of international concern. There is an emergent requirement to find potential therapeutics to effectively counter this fast mutating SARS-CoV-2 virus-induced pathogenicity. Virus-infected host cells switch their metabolism to a more glycolytic phenotype. This switch induced by the virus is needed for faster production of ATP and higher levels of anabolic i...
Topics
Open a Topic to create a Post that cites this publication.
- Animal Disease Management and Epidemiology
- Cytomegalovirus and herpesvirus research
- Diet, Metabolism, and Disease
- Herpesvirus Infections and Treatments
- Liver Disease Diagnosis and Treatment
- Metabolism, Diabetes, and Cancer
- Viral-associated cancers and disorders
- Viral gastroenteritis research and epidemiology
Identifiers and source
- Literature Corpus work
- 7ca317e0-460f-5470-b215-715bd62e39ec
- DOI
- 10.2139/ssrn.3981554
